Eargo, Inc.

Eargo, Inc. (Nasdaq: EAR), relating to its proposed sale to an affiliate of Patient Square Capital. Under the terms of the agreement, EAR shareholders will receive $2.55 in cash per share they own.

To receive more information regarding the investigation of Eargo, Inc. please fill out the form below.